CNCR Summary


The Loncar Cancer Immunotherapy ETF

ETF Information as of 11/16/2017

ETF Summary

ETF Info
Primary Exchange NASDAQ
Ticker CNCR
Index Symbol LCINDX
Index Provider Loncar Investments, LLC
Index Calculator Indxx, LLC
CUSIP 26922A826
Net Assets $40,459,411.50
Shares Outstanding 1,650,000
Number of Holdings 31
Weighting Equal-Weighted
Rebalanced Semi-Annually
Reconstituted Semi-Annually
Fund Inception Date 10/13/15
Management Fee 0.79%
Gross Expense Ratio 0.79%
Net Asset Value $24.52
Daily Change
Market Price
Closing Price $24.43
Daily Change $0.43
Premium Discount
NAV $24.52
Mid-Point $24.43
Premium/Discount -0.37%
Ex-Date 12/29/2015
Record Date 12/31/2015
Payable Date 1/4/2016
Amount $0.10551286
Short-Term Capital Gains N/A

The fund's investment in securities that are less actively traded or over time experience decreased trading volume may affect adversely the fund's ability to make dividend distributions.

Download Investor Materials